Assist in matters necessary for Advocacy Day planning on The Hill; Arrange meetings and appointments for NFXF officials; Work to encourage Members to act favorably on matters of interest and benefit to NFXF; Encourage Members to meet with constituents impacted by Fragile X.
Duration: February 6, 2020
to
present
General Issues: Government Issues , Medical/Disease Research/Clinical Labs , Education , Health Issues
Spending: about $255,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2020: U.S. Senate, House of Representatives
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, Watkins & Eager PLLC lobbied for National Fragile X Foundation , earning $15,000. The report was filed on April 8.
Original Filing: 301547150.xml
Lobbying Issues
Assist in matters necessary for Advocacy Day planning on The Hill; Arrange meetings and appointments for NFXF officials; Work to encourage Members to act favorably on matters of interest and benefit to NFXF; Encourage Members to meet with constituents impacted by Fragile X.
Agencies Lobbied
U.S. Senate
Type of Issue
Government Issues/Disease Research/Clinical Labs
4th Quarter, 2023
In Q4, Watkins & Eager PLLC lobbied for National Fragile X Foundation , earning $15,000. The report was filed on Jan. 8.
Original Filing: 301522266.xml
Lobbying Issues
Assist in matters necessary for Advocacy Day planning on The Hill; Arrange meetings and appointments for NFXF officials; Work to encourage Members to act favorably on matters of interest and benefit to NFXF; Encourage Members to meet with constituents impacted by Fragile X.
Agencies Lobbied
U.S. Senate
Type of Issue
Government Issues/Disease Research/Clinical Labs
3rd Quarter, 2023
In Q3, Watkins & Eager PLLC lobbied for National Fragile X Foundation , earning $15,000. The report was filed on Oct. 4, 2023.
Original Filing: 301497522.xml
Lobbying Issues
Assist in matters necessary for Advocacy Day planning on The Hill; Arrange meetings and appointments for NFXF officials; Work to encourage Members to act favorably on matters of interest and benefit to NFXF; Encourage Members to meet with constituents impacted by Fragile X.
Agencies Lobbied
U.S. Senate
Type of Issue
Government Issues/Disease Research/Clinical Labs
2nd Quarter, 2023
In Q2, Watkins & Eager PLLC lobbied for National Fragile X Foundation , earning $15,000. The report was filed on July 18, 2023.
Original Filing: 301479119.xml
Lobbying Issues
Assist in matters necessary for Advocacy Day planning on The Hill; Arrange meetings and appointments for NFXF officials; Work to encourage Members to act favorably on matters of interest and benefit to NFXF; Encourage Members to meet with constituents impacted by Fragile X.
Agencies Lobbied
U.S. Senate
Type of Issue
Government Issues/Disease Research/Clinical Labs
1st Quarter, 2023
In Q1, Watkins & Eager PLLC lobbied for National Fragile X Foundation , earning $15,000. The report was filed on April 5, 2023.
Original Filing: 301449042.xml
Lobbying Issues
Assist in matters necessary for Advocacy Day planning on The Hill; Arrange meetings and appointments for NFXF officials; Work to encourage Members to act favorably on matters of interest and benefit to NFXF; Encourage Members to meet with constituents impacted by Fragile X.
Agencies Lobbied
U.S. Senate
Type of Issue
Government Issues/Disease Research/Clinical Labs
4th Quarter, 2022
In Q4, Watkins & Eager PLLC lobbied for National Fragile X Foundation , earning $15,000. The report was filed on Jan. 9, 2023.
Original Filing: 301425566.xml
Lobbying Issues
Assist in matters necessary for Advocacy Day planning on The Hill; Arrange meetings and appointments for NFXF officials; Work to encourage Members to act favorably on matters of interest and benefit to NFXF. Encourage Members to meet with constituents impacted by Fragile X.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Encourage Members to act favorably on legislation that would benefit those impacted by Fragile X & their constituents; possible trail to help individuals with Fragile X.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Educate Members & their staffers on Fragile X and how it can impact their constituents directly affected by Fragile X
Agencies Lobbied
U.S. Senate
3rd Quarter, 2022
In Q3, Watkins & Eager PLLC lobbied for National Fragile X Foundation , earning $15,000. The report was filed on Oct. 12, 2022.
Original Filing: 301403000.xml
Lobbying Issues
Assist in matters necessary for Advocacy Day planning on The Hill; Arrange meetings and appointments for NFXF officials; Work to encourage Members to act favorably on matters of interest and benefit to NFXF. Encourage Members to meet with constituents impacted by Fragile X.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Encourage Members to act favorably on legislation that would benefit those impacted by Fragile X & their constituents; possible trail to help individuals with Fragile X.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Educate Members & their staffers on Fragile X and how it can impact their constituents directly affected by Fragile X
Agencies Lobbied
U.S. Senate
2nd Quarter, 2022
In Q2, Watkins & Eager PLLC lobbied for National Fragile X Foundation , earning $15,000. The report was filed on July 13, 2022.
Original Filing: 301380051.xml
Lobbying Issues
Assist in matters necessary for Advocacy Day planning on The Hill; Arrange meetings and appointments for NFXF officials; Work to encourage Members to act favorably on matters of interest and benefit to NFXF. Encourage Members to meet with constituents impacted by Fragile X.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Encourage Members to act favorably on legislation that would benefit those impacted by Fragile X & their constituents; possible trail to help individuals with Fragile X.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Educate Members & their staffers on Fragile X and how it can impact their constituents directly affected by Fragile X
Agencies Lobbied
U.S. Senate
1st Quarter, 2022
In Q1, Watkins & Eager PLLC lobbied for National Fragile X Foundation , earning $15,000. The report was filed on April 19, 2022.
Original Filing: 301360589.xml
Lobbying Issues
Assist in matters necessary for Advocacy Day planning on The Hill; Arrange meetings and appointments for NFXF officials; Work to encourage Members to act favorably on matters of interest and benefit to NFXF. Encourage Members to meet with constituents impacted by Fragile X.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Encourage Members to act favorably on legislation that would benefit those impacted by Fragile X & their constituents.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Educate Members & their staffers on Fragile X and how it can impact their constituents directly affected by Fragile X
Agencies Lobbied
U.S. Senate
4th Quarter, 2021
In Q4, Watkins & Eager PLLC lobbied for National Fragile X Foundation , earning $15,000. The report was filed on Jan. 10, 2022.
Original Filing: 301320874.xml
Lobbying Issues
Assist in matters necessary for Advocacy Day planning on The Hill; Arrange meetings and appointments for NFXF officials; Work to encourage Members to act favorably on matters of interest and benefit to NFXF. Encourage Members to meet with constituents impacted by Fragile X.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Encourage Members to act favorably on legislation that would benefit those impacted by Fragile X & their constituents.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Educate Members & their staffers on Fragile X and how it can impact their constituents directly affected by Fragile X
Agencies Lobbied
U.S. Senate
3rd Quarter, 2021
In Q3, Watkins & Eager PLLC lobbied for National Fragile X Foundation , earning $15,000. The report was filed on Oct. 18, 2021.
Original Filing: 301301181.xml
Lobbying Issues
Assist in matters necessary for Advocacy Day planning on The Hill; Arrange meetings and appointments for NFXF officials; Work to encourage Members to act favorably on matters of interest and benefit to NFXF. Encourage Members to meet with constituents impacted by Fragile X.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Encourage Members to act favorably on legislation that would benefit those impacted by Fragile X & their constituents.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Educate Members & their staffers on Fragile X and how it can impact their constituents directly affected by Fragile X
Agencies Lobbied
U.S. Senate
2nd Quarter, 2021
In Q2, Watkins & Eager PLLC lobbied for National Fragile X Foundation , earning $15,000. The report was filed on July 8, 2021.
Original Filing: 301274285.xml
Lobbying Issues
Assist in matters necessary for Advocacy Day planning on The Hill; Arrange meetings and appointments for NFXF officials; Work to encourage Members to act favorably on matters of interest and benefit to NFXF. Encourage Members to meet with constituents impacted by Fragile X.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Encourage Members to act favorably on legislation that would benefit those impacted by Fragile X & their constituents.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Educate Members & their staffers on Fragile X and how it can impact their constituents directly affected by Fragile X
Agencies Lobbied
U.S. Senate
1st Quarter, 2021
In Q1, Watkins & Eager PLLC lobbied for National Fragile X Foundation , earning $15,000. The report was filed on April 19, 2021.
Original Filing: 301259391.xml
Lobbying Issues
Assist in matters necessary for Advocacy Day planning on The Hill; Arrange meetings and appointments for NFXF officials; Work to encourage Members to act favorably on matters of interest and benefit to NFXF. Encourage Members to meet with constituents impacted by Fragile X.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Encourage Members to act favorably on legislation that would benefit those impacted by Fragile X & their constituents.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Educate Members & their staffers on Fragile X and how it can impact their constituents directly affected by Fragile X
Agencies Lobbied
U.S. Senate
4th Quarter, 2020
In Q4, Watkins & Eager PLLC lobbied for National Fragile X Foundation , earning $15,000. The report was filed on Jan. 8, 2021.
Original Filing: 301229287.xml
Lobbying Issues
Assist in matters necessary to lay the groundwork for 2020 Advocacy Day on The Hill; Arrange meetings and appointments with Members and their staffers for NFXF officials; Work to encourage Members to act favorably on matters of interest & benefit to the NFXF. Encourage Members to meet with constituents impacted by Fragile X.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work to assist in developing a legislative strategy for funding for training & development for Fragile X clinicians & other medical providers. Encourage Members to act favorably on matters of interest related to funding & research.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Work to assist in developing a strategy for funding for training & development for special education teachers.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2020
In Q3, Watkins & Eager PLLC lobbied for National Fragile X Foundation , earning $15,000. The report was filed on Oct. 5, 2020.
Original Filing: 301207437.xml
Lobbying Issues
Assist in matters necessary to lay the groundwork for 2020 Advocacy Day on The Hill; Arrange meetings and appointments with Members and their staffers for NFXF officials; Work to encourage Members to act favorably on matters of interest & benefit to the NFXF. Encourage Members to meet with constituents impacted by Fragile X.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work to assist in developing a legislative strategy for funding for training & development for Fragile X clinicians & other medical providers. Encourage Members to act favorably on matters of interest related to funding & research.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Work to assist in developing a strategy for funding for training & development for special education teachers.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2020
In Q2, Watkins & Eager PLLC lobbied for National Fragile X Foundation , earning $15,000. The report was filed on July 7, 2020.
Original Filing: 301185662.xml
Lobbying Issues
Assist in matters necessary to lay the groundwork for 2020 Advocacy Day on The Hill; Arrange meetings and appointments with Members and their staffers for NFXF officials; Work to encourage Members to act favorably on matters of interest & benefit to the NFXF. Encourage Members to meet with constituents impacted by Fragile X.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work to assist in developing a legislative strategy for funding for training & development for Fragile X clinicians & other medical providers. Encourage Members to act favorably on matters of interest related to funding & research.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Work to assist in developing a strategy for funding for training & development for special education teachers.
Agencies Lobbied
U.S. Senate
1st Quarter, 2020
In Q1, Watkins & Eager PLLC lobbied for National Fragile X Foundation , earning $15,000. The report was filed on April 15, 2020.
Original Filing: 301167125.xml
Lobbying Issues
Assist in matters necessary to lay the groundwork for 2020 Advocacy Day on The Hill; Arrange meetings and appointments with Members and their staffers for NFXF officials; Work to encourage Members to act favorably on matters of interest & benefit to the NFXF. Encourage Members to meet with constituents impacted by Fragile X.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work to assist in developing a legislative strategy for funding for training & development for Fragile X clinicians & other medical providers. Encourage Members to act favorably on matters of interest related to funding & research.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Work to assist in developing a strategy for funding for training & development for special education teachers.
Agencies Lobbied
U.S. Senate
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...